As per a recent reportpublished by Future Market Insights, the global demand for therapeutic respiratory devices market is expected to rise at a 3.5% CAGR to acquire a valuation ofUS$ 68.7 Bn by the end of the forecast period owing to an ageing population,
natural catastrophes, and air pollution throughout the world.
The sales of therapeutic respiratory devices are being driven by theincreased prevalence of respiratory disorders and rapid technical
improvements. Furthermore, the market is predicted to increase due to the
growing adoption of therapeuticrespiratory devices market such as humidifiers, nebulizers, and oxygenconcentrators. Long-term respiratorytherapy for critical care, emergency respiratory devices for rescue applications,and mobile home respiratory devices are among the several types of respiratory devices available. Therapeutic advances in respiratory diseases is an open-access magazine that publishes peer-reviewedoriginal research papers, reviews, and scholarly commentary on cutting-edge
research and studies in the treatment of respiratory illnesses.
"Physicians and patients choose respiratory therapy devices for thetreatment of respiratory problems owing to the medical intervention in both
acute and chronic patient care."
Key Takeaways
· Existenceof modern healthcare facilities in the United States and Canada, the therapeutic respiratory devices market inNorth America gained over 36% market share in 2021.
· TheAsia Pacific is predicted to expand the quickest throughout the forecast
period, owing to factors such as increased asthma incidence in adults and
children, as well as technology improvements.
· Additionally,the market expansion would be aided by rising healthcare awareness and improved
healthcare infrastructure.
· Theclinical trial of Tempol for the treatment of COVID-19 by Adams Respiratory Therapeutics Inc hassurpassed enrollment expectations.
· COPD isestimated to affect 10% of adults aged 75 and older in the United States, according
to the Journal of the Italian Society of Gerontology and Geriatrics.
· Accordingto statistics issued by the Global Initiative for Asthma (GINA), an estimated
100 million people with asthma are expected to be diagnosed by 2025.
Competitive Landscape
Carefusion Corporation, G.E.Healthcare, Chart industries, Philips Healthcare, Compumedics Ltd., Smiths
Medical, Covidien PLC, Invacare, Fisher and Paykel, and Mindray are some of the
major respiratory device companies.
Acquisitions and mergers, thelaunch of new products and services, partnerships and joint ventures, MoU
agreements, V.C. and funding activities, R&D activities, and geographic
expansion, among other noteworthy activities by key players in the therapeutic
respiratory devices market, are among the key strategic developments in the
competitive landscape.
· Acapella,a select blue vibratory PAP therapy device, was released by Smiths Medical in
April 2021. It is a drug-free supplementary therapy for people with asthma,
COPD, cystic fibrosis, and lung illness that aids in the evacuation of
secretions.
· KoninklijkePhilips N.V. finalized the acquisition of BioTelemetry, Inc., a firm located in
the United States, in February 2021. This aided in the expansion of Philips'
product line, resulting in increased sales of therapeutic respiratory devices.
Key Segments
- By Product:
- Positive Airway Pressure (PAP) Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Auto-titrating Positive Airway Pressure (APAP) Devices
- Bi-level Positive Airway Pressure (BiPAP) Devices
- Oxygen Concentrator
- Fixed Oxygen Concentrators
- Portable Oxygen Concentrators
- Ventilators
- Adult Ventilators
- Neonatal Ventilators
- Inhalers
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- Soft Mist Inhaler (SMI)
- Nebulizers
- Compressor-based Nebulizers
- Piston-based Hand-held Nebulizers
- Ultrasonic Nebulizers
- Humidifiers
- Heated Humidifiers
- Passover Humidifiers
- Integrated Humidifiers
- Built-in Humidifiers
- Standalone Humidifiers
- Others
- By Application:
- COPD
- Obstructive Sleep Apnea
- Asthma
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Others
- By End-use:
- Hospital
- Homecare Settings
- Emergency Centers
- By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- South Africa
- UAE
- Saudi Arabia
Information Source:
